Expression of leukocyte inhibitory immunoglobulinlike transcript 3 receptors by ovarian tumors in laying hen model of spontaneous ovarian cancer

Translational Oncology

Volumn 5, Issue 2, 2012, Pages 85-91

  Khan, Mohammad Faisal ^a   Bahr, Janice M ^b   Yellapa, Aparna ^a   Bitterman, Pincas ^a   Abramowicz, Jacques S ^a   Edassery, Seby L ^a   Basu, Sanjib ^a   Rotmensch, Jacob ^a   Barua, Animesh ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER STAGING; CHROMOSOME 5Q; COLON CANCER; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENOME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; METHYLATION;

EID: 84859535970     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.11328     Document Type: Article

References (35)

1. Jemal A, Siegel R, Xu J, and Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin 60, 277-300.
2. Goodman MT, Correa CN, Tung KH, Roffers SD, Cheng Wu X, Young JL Jr, Wilkens LR, Carney ME, and Howe HL (2003). Stage at diagnosis of ovarian cancer in the United States, 1992-1997. Cancer 97, 2648-2659.
3. Ries LA (1993). Ovarian cancer. Survival and treatment differences by age. Cancer 71, 524-529.
4. Zou W (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6, 295-307.
5. Beyer M and Schultze JL (2006). Regulatory T cells in cancer. Blood 108, 804-811.
6. Figdor CG, de Vries IJ, Lesterhuis WJ, and Melief CJ (2004). Dendritic cell immunotherapy: mapping the way. Nat Med 10, 475-480.
7. Dougan M and Dranoff G (2009). Immune therapy for cancer. Annu Rev Immunol 27, 83-117.
8. Shu S, Cochran AJ, Huang RR, Morton DL, and Maecker HT (2006). Immune responses in the draining lymph nodes against cancer: implications for immunotherapy. Cancer Metastasis Rev 25, 233-242.
9. Yigit R, Massuger LF, Figdor CG, and Torensma R (2010). Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Oncol 117, 366-372.
10. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon- Hogan M, Conejo-Garcia JR, Zhang L, Burow M, et al. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10, 942-949.
11. Li MO, Wan YY, Sanjabi S, Robertson AK, and Flavell RA (2006). Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24, 99-146.
12. Kriegel MA, Li MO, Sanjabi S, Wan YY, and Flavell RA (2006). Transforming growth factor-β: recent advances on its role in immune tolerance. Curr Rheumatol Rep 8, 138-144.
13. Liu Z, Guo B, and Lopez RD (2009). Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human γδ-T cells: implications in the design of γδ-T-cell-based immunotherapies for pancreatic cancer. J Gastroenterol Hepatol 24, 900-911
14. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, and Levings MK (2001). Type 1 T regulatory cells. Immunol Rev 182, 68-79.
15. Liu Z, Tugulea S, Cortesini R, and Suciu Foca N (1998). Specific suppression of T helper alloreactivity by allo MHC class I-restricted CD8+CD28- T cells. Int Immunol 10, 775-783.
16. Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, Curiel T, Lange A, and Zou W (2005). Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 65, 5020-5026.
17. Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, et al. (2006). B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203, 871-881.
18. Salazar-Onfray F (1999). Interleukin-10: a cytokine used by tumors to escape immunosurveillance. Med Oncol 16, 86-94.
19. Suciu-Foca N, Feirt N, Zhang QY, Vlad G, Liu Z, Lin H, Chang CC, Ho EK, Colovai AI, Kaufman H, et al. (2007). Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients. J Immunol 178, 7432-7441.
20. Kim-Schulze S, Scotto L, Vlad G, Piazza F, Lin H, Liu Z, Cortesini R, and Suciu- FocaN (2006). Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol 176, 2790-2798.
21. Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, and Grizzle WE (2001). Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81, 373-379.
22. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Edassery SL, Rotmensch J, and Luborsky JL (2009). Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 19, 531-539.
23. Viertlboeck BC, Habermann FA, Schmitt R, Groenen MA, Du Pasquier L, and Gobel TW (2005). The chicken leukocyte receptor complex: a highly diverse multigene family encoding at least six structurally distinct receptor types. J Immunol 175, 385-393.
24. Dennis G Jr, Kubagawa H, and Cooper MD (2000). Paired Ig-like receptor homologs in birds and mammals share a common ancestor with mammalian Fc receptors. Proc Natl Acad Sci USA 97, 13245-13250.
25. Barua A, Abramowicz JS, Bahr JM, Bitterman P, Dirks A, Holub KA, Sheiner E, Bradaric MJ, Edassery SL, and Luborsky JL (2007). Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans? J Ultrasound Med 26, 909-919.
26. Barua A, Bitterman P, Bahr JM, Bradaric MJ, Hales DB, Luborsky JL, and Abramowicz JS (2010). Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer. J Ultrasound Med 29, 173-182.
27. Giles JR, Olson LM, and Johnson PA (2006). Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med (Maywood) 231, 1718-1725.
28. Barua A, Edassery SL, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, and Luborsky JL (2009). Prevalence of antitumor antibodies in laying hen model of human ovarian cancer. Int J Gynecol Cancer 19, 500-507.
29. Hong YH, Lillehoj HS, Lee SH, Dalloul RA, and Lillehoj EP (2006). Analysis of chicken cytokine and chemokine gene expression following Eimeria acervulina and Eimeria tenella infections. Vet Immunol Immunopathol 114, 209-223.
30. Poschke I, Mougiakakos D, and Kiessling R (2011). Camouflage and sabotage: tumor escape from the immune system. Cancer Immunol Immunother 60, 1161-1171.
31. Vlad G, Chang CC, Colovai AI, Vasilescu ER, Cortesini R, and Suciu-Foca N (2010). Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int Rev Immunol 29, 119-132.
32. Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, and Colonna M (1997). A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185, 1743-1751.
33. Manavalan JS, Kim-Schulze S, Scotto L, Naiyer AJ, Vlad G, Colombo PC, Marboe C, Mancini D, Cortesini R, and Suciu-Foca N (2004). Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16, 1055-1068.
34. Colovai AI, Tsao L, Wang S, Lin H, Wang C, Seki T, Fisher JG, Menes M, Bhagat G, Alobeid B, et al. (2007). Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia. Cytometry B Clin Cytom 72, 354-362.
35. Barua A, Bitterman P, Bahr JM, Basu S, Sheiner E, Bradaric MJ, Hales DB, Luborsky JL, and Abramowicz JS (2011). Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model. J Ultrasound Med 30, 333-345.